Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111887 · ClinicalTrials.gov registry record · NA
Pilot Study Comparing Two Versions of Group Cognitive-behavioral Indicated Prevention Programs
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT04111887: Completed NA study, sponsored by Oregon Research Institute.
NCT04111887 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04111887, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two depression prevention programs and a control brochure for college students. Participants may experience reductions in depressive symptoms and prevention of future depression.
Primary Outcome
Evaluate change (if any) by using the Kiddie Schedule for Affective Disorders and Schizophrenia at the 6 week, 3 month and 6 month marks.
Interventions
- BEHAVIORAL Group-based therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT04111887 record still lists
NCT04111887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Group-based therapy is the first listed.
NCT04111887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04111887 about?
NCT04111887 is a clinical study titled "Pilot Study Comparing Two Versions of Group Cognitive-behavioral Indicated Prevention Programs". The purpose of this study is to compare the effectiveness of two depression prevention programs and a control brochure for college students. Participants may experience reductions in depressive symptoms and prevention of future depression.
What is the current status of trial NCT04111887?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2017-10-10. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT04111887?
The interventions under investigation include: Group-based therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04111887?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04111887's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI